Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 10 | 2025 | 59 | 3.300 |
Why?
|
| Community-Institutional Relations | 3 | 2026 | 219 | 0.940 |
Why?
|
| Community-Based Participatory Research | 2 | 2026 | 352 | 0.810 |
Why?
|
| Internet | 1 | 2024 | 236 | 0.780 |
Why?
|
| Depression | 6 | 2025 | 863 | 0.740 |
Why?
|
| Decision Making | 1 | 2024 | 249 | 0.700 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 497 | 0.660 |
Why?
|
| Heart Failure | 1 | 2024 | 302 | 0.650 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 539 | 0.580 |
Why?
|
| Quality of Life | 5 | 2023 | 616 | 0.410 |
Why?
|
| Humans | 30 | 2026 | 43102 | 0.370 |
Why?
|
| Georgia | 5 | 2026 | 192 | 0.360 |
Why?
|
| Adult | 17 | 2025 | 13872 | 0.350 |
Why?
|
| Middle Aged | 15 | 2025 | 12222 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 760 | 0.330 |
Why?
|
| Telemedicine | 2 | 2024 | 234 | 0.280 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 423 | 0.250 |
Why?
|
| Male | 15 | 2025 | 23409 | 0.250 |
Why?
|
| Female | 16 | 2025 | 24698 | 0.250 |
Why?
|
| Aged | 7 | 2025 | 8214 | 0.240 |
Why?
|
| Perception | 2 | 2025 | 215 | 0.240 |
Why?
|
| Seizures | 2 | 2023 | 79 | 0.230 |
Why?
|
| Fraud | 1 | 2024 | 9 | 0.220 |
Why?
|
| Life Style | 2 | 2023 | 334 | 0.200 |
Why?
|
| Focus Groups | 1 | 2025 | 423 | 0.200 |
Why?
|
| Adaptation, Psychological | 3 | 2022 | 420 | 0.190 |
Why?
|
| Databases, Factual | 2 | 2019 | 341 | 0.170 |
Why?
|
| Chronic Disease | 1 | 2024 | 549 | 0.170 |
Why?
|
| Hypertension | 4 | 2016 | 835 | 0.160 |
Why?
|
| Suicide | 1 | 2021 | 140 | 0.160 |
Why?
|
| Epidemiologic Studies | 1 | 2019 | 33 | 0.150 |
Why?
|
| Phenotype | 2 | 2019 | 780 | 0.140 |
Why?
|
| Stress, Psychological | 3 | 2022 | 661 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 749 | 0.140 |
Why?
|
| United States | 5 | 2023 | 5205 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2019 | 187 | 0.130 |
Why?
|
| Disease Management | 1 | 2017 | 70 | 0.120 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2016 | 27 | 0.120 |
Why?
|
| Immune System Diseases | 1 | 2016 | 21 | 0.120 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2016 | 6 | 0.120 |
Why?
|
| Dinoprost | 1 | 2016 | 19 | 0.120 |
Why?
|
| Genetic Loci | 1 | 2016 | 104 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2016 | 91 | 0.120 |
Why?
|
| Leukocytes | 1 | 2016 | 80 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2016 | 81 | 0.120 |
Why?
|
| Telomere | 1 | 2016 | 59 | 0.120 |
Why?
|
| Social Class | 1 | 2017 | 291 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2019 | 1604 | 0.110 |
Why?
|
| Sickle Cell Trait | 1 | 2014 | 19 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 863 | 0.110 |
Why?
|
| Albuminuria | 1 | 2014 | 78 | 0.110 |
Why?
|
| Prejudice | 2 | 2005 | 116 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2016 | 430 | 0.100 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 3156 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 193 | 0.090 |
Why?
|
| Anticonvulsants | 2 | 2021 | 40 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2023 | 2853 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 1081 | 0.070 |
Why?
|
| Young Adult | 4 | 2023 | 5080 | 0.070 |
Why?
|
| Adolescent | 3 | 2023 | 6081 | 0.060 |
Why?
|
| Risk Factors | 4 | 2016 | 3994 | 0.060 |
Why?
|
| Social Justice | 1 | 2005 | 65 | 0.050 |
Why?
|
| Motor Activity | 1 | 2006 | 437 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2019 | 1600 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2026 | 574 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 1759 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 310 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2023 | 161 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2022 | 162 | 0.040 |
Why?
|
| Weight Loss | 1 | 2021 | 137 | 0.040 |
Why?
|
| Psychometrics | 1 | 2022 | 358 | 0.040 |
Why?
|
| Health Promotion | 1 | 2026 | 704 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1612 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 1009 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2020 | 182 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 590 | 0.030 |
Why?
|
| Multigene Family | 1 | 2017 | 105 | 0.030 |
Why?
|
| Preventive Medicine | 1 | 2017 | 16 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 50 | 0.030 |
Why?
|
| Social Support | 1 | 2020 | 445 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2016 | 12 | 0.030 |
Why?
|
| Platelet Count | 1 | 2016 | 13 | 0.030 |
Why?
|
| Adipokines | 1 | 2016 | 28 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 737 | 0.030 |
Why?
|
| Quality Control | 1 | 2016 | 42 | 0.030 |
Why?
|
| Mississippi | 1 | 2016 | 129 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 118 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 103 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 206 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 150 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 140 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 701 | 0.030 |
Why?
|
| Lipids | 1 | 2016 | 256 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 147 | 0.030 |
Why?
|
| Risk | 1 | 2014 | 287 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 408 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 327 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 509 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2016 | 363 | 0.020 |
Why?
|
| Women's Health | 1 | 2014 | 160 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1063 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1285 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 734 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 783 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 925 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1234 | 0.020 |
Why?
|
| Health Care Reform | 1 | 2005 | 36 | 0.010 |
Why?
|
| Systole | 1 | 2005 | 67 | 0.010 |
Why?
|
| Policy Making | 1 | 2005 | 35 | 0.010 |
Why?
|
| Diastole | 1 | 2005 | 47 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2005 | 112 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 638 | 0.010 |
Why?
|
| Incidence | 1 | 2005 | 1078 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 666 | 0.010 |
Why?
|
| Public Health | 1 | 2005 | 424 | 0.010 |
Why?
|